2.270USD+3.65%Mkt Cap: 3.53M USDP/E: —Last update: 2026-06-01
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunother…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap3.53M USD
Enterprise Value-3.63M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-13.39M USD
Revenue/Share—
Last Price2.270 USD
Fiscal Year EndMar 2025
MR QuarterDec 2025
Employees9
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS00808Y3071
Valuation
P/E (Trailing)—
P/E (Forward)-2.26
PEG—
EV/EBITDA0.52
EV/Revenue—
P/S—
P/B0.32
EPS (TTM)-48.46
EPS (Forward)-0.98
52W Range
1.3603% of range30.40
52W High30.40 USD
52W Low1.360 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-261.31%
ROA-181.91%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.65M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-128.73%
Net Debt-6.54M USD
Net Debt/EBITDA0.93
Balance Sheet
Debt/Equity0.13
Current Ratio5.68
Quick Ratio5.53
Book Value/Sh6.898 USD
Cash/Share5.290 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateOct 15, 2019
Splits
Last Split1:10
Split DateOct 20, 2025
Analyst Consensus
Rating—
Target (Mean)4.750 USD
Target Range1.500 USD – 8.000 USD
# Analysts2
Ownership
Shares Out.1.57M
Float1.24M
Insiders7.51%
Institutions9.76%
Short Interest
Short Ratio0.8d
Short % Float1.85%
Short % Out.1.84%
Shares Short28.84K
Short (prev mo.)35.09K
Technical
SMA 502.251 (+0.9%)
SMA 2004.510 (-49.7%)
Beta1.50
S&P 52W Chg27.94%
Avg Vol (30d)1.00M
Avg Vol (10d)2.96M
Technical Indicators
RSI (14)47.5
MACD0.0653
MACD Signal0.0270
MACD Hist.+0.0383
BB Upper2.760 USD
BB Middle2.280 USD
BB Lower1.800 USD
BB Width42.14%
ATR (14)0.2520 USD
Vol Ratio (20d)0.54x